We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Rights & Issues Investment Trust plc (RIII) Ord 25p

Sell:2,340.00p Buy:2,380.00p 0 Change: 60.00p (2.56%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:2,340.00p
Buy:2,380.00p
Change: 60.00p (2.56%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:2,340.00p
Buy:2,380.00p
Change: 60.00p (2.56%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

The objective is to exceed the benchmark index over the long term whilst managing risk. The Company invests in equities with an emphasis on smaller companies. UK smaller companies will normally constitute at least 80% of the investment portfolio. UK smaller companies include both listed securities and those quoted on the Alternative Investment Market.

Fee Structure

Management fee is payable quarterly to the Investment Manager at 0.60% p.a. on the Companys NAV up to and including GBP 200m and at 0.50% p.a. on the Companys NAV in excess of GBP 200m.

Dividend Policy

The Board continues to operate a progressive dividend policy. The Board intends to declear dividends semi-annually.

ASSET SPLIT

Total number of holdings: 37.

Trust Manager

Matthew Cable

Manager Bio

Matt is an Investment Manager in the UK Small & Mid Cap Equities team. Before joining Jupiter, Matt worked at M&G for 11 years, during which time he was a member of the smaller companies team, and was involved in the running of c. £850m of assets. He began his investment career in 2001. Matt has a degree in pharmacology and is a CFA® charterholder.

Board Of Directors

Andrew HostyChairman, Simon Knott, Jonathan Roper, Helen Vaughan

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.